Sun Pharma Announces USFDA Approval For Generic Strattera(R) Capsules

Links shared publicly online about this topic.

  • 903
    total visits

Sun Pharma Announces USFDA Approval For Generic Strattera(R) Capsules

medicalnewstoday.com

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Applic

View full resource at medicalnewstoday.com

Tags: ADHD, Drug, Pharma

  • Share

Most Recently Shared on September 2, 2010 at 3:00 pm By:

mnt_drugapprov MNT Drug Approvals

Sun Pharma Announces USFDA Approval For Generic Strattera(R) Capsules http://mnt.to/3J9z #regulatory

2 years ago...

Also Shared By:

MNT ADHD & ADD News MNT ADHD & ADD News

Sun Pharma Announces Launch Of Generic Exelon(R) In US

medicalnewstoday.com — “Sun Pharma announced launch of generic Exelon®, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 7, 2010 at 1:07 pm By:

mnt_parkinsons MNT Parkinson's News Health News

Sun Pharma Announces Launch Of Generic Exelon(R) In US http://mnt.to/3FMX #parkinsons

2 years ago...

Sun Pharma introduces generic rivastigmine capsules in U.S. market

news-medical.net — “Sun Pharma announced launch of generic Exelon, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 2, 2010 at 6:23 am By:

NewsMedical News-Medical.Net Health News

Sun Pharma introduces generic rivastigmine capsules in U.S. market: Sun Pharma announced launch of generic Exelon,... http://bit.ly/8Xi8nH

2 years ago...

Advertisement